BindingDB logo
myBDB logout

52 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27876467 9 A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease.EBI Tehran University of Medical Sciences
24731278 22 Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages.EBI Bar-Ilan University
24148993 4 Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.EBI Punjabi University
23199476 36 Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.EBI Universit£
15317459 46 Modulation of binding strength in several classes of active site inhibitors of acetylcholinesterase studied by comparative binding energy analysis.EBI Universitat De Barcelona
23151013 56 Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.EBI Bar-Ilan University
22243648 112 New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, andß-amyloid-reducing properties.EBI Instituto De Qu£Mica M£Dica
22185619 50 Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.EBI Universitat De Barcelona
20575555 45 Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.EBI Universidad Autonoma De Madrid
20176490 8 Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus.EBI Institute of Plant Biochemistry
18517184 47 Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.EBI Laboratori De Qu�Mica Farmac�Utica (Unitat Associada Al Csic)
18479118 114 Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.EBI Universit£
17854153 2 Brunneins A-C, beta-carboline alkaloids from Cortinarius brunneus.EBI Institute of Plant Biochemistry
17904850 3 Cryptadines A and B, novel C27N3-type pentacyclic alkaloids from Lycopodium cryptomerinum.EBI Hoshi University
17154513 56 Binding of 13-amidohuprines to acetylcholinesterase: exploring the ligand-induced conformational change of the gly117-gly118 peptide bond in the oxyanion hole.EBI Universitat De Barcelona
15139762 133 Interaction of cycloSal-pronucleotides with cholinesterases from different origins. A structure-activity relationship.EBI University of Hamburg
12502352 28 Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.EBI Universit£
11831902 12 Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors.EBI Institute of Research
11741490 18 Synthesis, in vitro pharmacology, and molecular modeling of syn-huprines as acetylcholinesterase inhibitors.EBI Universitat De Barcelona
11101357 84 New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.EBI Universitat De Barcelona
10464010 40 Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.EBI Universitat De Barcelona
2033583 10 Structure-activity studies on a potent antagonist to organophosphate-induced toxicity.EBI University of Iowa
2913310 68 Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 2. Preparation and in vitro and in vivo evaluation of 1-(alkoxymethyl)-2-[(hydroxyimino)methyl]-3-methylimida zolium halides for reactivation of organophosphorus-inhibited acetylcholinesterases.EBI Sri International
12031333 5 Synthesis of more potent analogues of the acetylcholinesterase inhibitor, huperzine B.EBI Georgetown University Medical Center
11078202 4 Synthesis, chiral chromatographic separation, and biological activities of the enantiomers of 10,10-dimethylhuperzine A.EBI Georgetown University Medical Center
 9 Synthesis of ()-10,10-dimethylhuperzine A a huperzine analogue possessing a slower enzyme off-rateEBI TBA
21420206 38 N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.EBI Instituto De Qu£Mica M£Dica
21459491 96 Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.EBI Universit£
21417225 116 Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivity.EBI Universidad De Granada
21163662 39 Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.EBI Laboratorio De Radicales Libres Y Qu�Mica Computacional (Iqog, Csic)
20926162 14 Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow's neuroprotective therapies against neurodegenerative diseases.EBI Instituto De Qu£Mica M£Dica
20545360 38 Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.EBI Instituto De Quimica Medica
19856923 40 Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.EBI Instituto De Quimica Medica (Csic)
 22 Synthesis, insecticidal and anti-acetylcholinesterase activity of a new class of heterocyclic methanesulfonatesEBI TBA
18585045 22 Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors.EBI Università
18485717 3 Lycoparins A-C, new alkaloids from Lycopodium casuarinoides inhibiting acetylcholinesterase.EBI Hoshi University
17188496 3 Carinatumins A-C, new alkaloids from Lycopodium carinatum inhibiting acetylcholinesterase.EBI Hoshi University
30739821 57 Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines.EBI Hospital Universitario De La Princesa
9871563 31 Synthesis and activity studies of N-[omega-N'-(adamant-1'-yl)aminoalkyl]- 2-(4'-dimethylaminophenyl)acetamides: in the search of selective inhibitors for the different molecular forms of acetylcholinesterase.EBI Istituto Di Strutturistica Chimica G. Giacomello
30744931 170 Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).EBI Csir-Central Drug Research Institute
9301662 50 Synthesis and study of thiocarbonate derivatives of choline as potential inhibitors of acetylcholinesterase.EBI University of North Texas
29609119 9 Benzopyrroloxazines containing a bridgehead nitrogen atom as promising scaffolds for the achievement of biologically active agents.EBI University of Calabria
29605809 19 Success stories of natural product-based hybrid molecules for multi-factorial diseases.EBI Punjabi University
29886321 20 Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.EBI Cnrs
28371641 32 Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.EBI China Pharmaceutical University
10411562 36 Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.BDB Merck Frosst Centre For Therapeutic Research
15239652 22 Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors.BDB Fujisawa Pharmaceutical
17941623 72 Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.BDB St. Jude Research Hospital
17154493 13 4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.BDB Irbm-Mrl